CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
for maintenance selinexor in participants with advanced or recurrent endometrial cancer. Participants with primary stage IV or recu...
Phase 3
Indianapolis, Indiana, United States and 76 other locations
(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...
Phase 3
Indianapolis, Indiana, United States and 202 other locations
This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have ...
Phase 2, Phase 3
Indianapolis, Indiana, United States and 82 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
Indianapolis, Indiana, United States and 162 other locations
drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...
Phase 1
Indianapolis, Indiana, United States and 75 other locations
The purpose of this study is to further evaluate the efficacy and safety of niraparib in patients with locally advanced or metastatic solid tumors an...
Phase 2
Indianapolis, Indiana, United States and 79 other locations
TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Com...
Phase 2
Muncie, Indiana, United States and 92 other locations
The purpose of this study is to compare pembrolizumab + adjuvant chemotherapy with placebo + adjuvant chemotherapy, with or without radiotherapy, wit...
Phase 3
Indianapolis, Indiana, United States and 230 other locations
consist of Part 1 which includes 7 cohorts of: urothelial bladder cancer, biliary tract cancer, cervical cancer, endometrial...
Phase 2
Muncie, Indiana, United States and 76 other locations
The purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial...
Phase 3
Indianapolis, Indiana, United States and 125 other locations
Clinical trials
Research sites
Resources
Legal